CODMAN HAKIM 82-3164Recalls & reported problems
Cerenovus, Inc. · CODMAN HAKIM Programmable Valve In-Line Valve Programmable in steps of 10mm H2O (98 Pa): 30mm H2O to 200mm H2O (294 Pa - 1960 Pa) Includes: Programmable Valve, Information Manual and Priming Adapter · Class 2 · Implant
All models of CODMAN HAKIM (17)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 6
- Deaths reported
- 0
- Injuries reported
- 6
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 10886704041566), received between Jun 14, 2022 and Aug 27, 2024 — classified as 6 injuries.
The most frequently reported specific device problem is “Activation, Positioning or Separation Problem” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Activation, Positioning or Separation Problem1
- Excess Flow or Over-Infusion1
- Infusion or Flow Problem1
- Insufficient Device Problem Information1
- Obstruction of Flow1
- Pressure Problem1
Patient problems
- Hematoma2
- Insufficient Information2
- No Clinical Signs, Symptoms or Conditions1
- Vomiting1
Recent adverse event reports
The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.
InjuryAug 27, 2024Pressure Problem; Pressure Problem
InjuryAug 15, 2023Activation, Positioning or Separation Problem; Activation, Positioning or Separation Problem
InjuryAug 2, 2022Excess Flow or Over-Infusion; Excess Flow or Over-Infusion
1 OF 2 REPORTS LINKED TO MFG REPORT NUMBER: 3013886523-2022-00359. A PHYSICIAN REPORTED A HAKIM PROGRAMMABLE VALVE WAS IMPLANTED IN A 15 YEAR-OLD MALE PATIENT TO TREAT AQUEDUCTAL STENOSIS WITH HYDROCEPHALUS BUT LATER DEVELOPED BILATERAL SUBDURAL COLLECTIONS. THE SUBDURAL COLLECTIONS WERE EVACUATED, SHUNT WAS REVISED AND CHANGED TO A PROGRAMMABLE VP SHUNT WITH PRESSURE AT 70MMH2O ON (B)(6) 2022. THEN PATIENT DEVELOPED RECURRENCE OF BILATERAL SUBDURAL COLLECTION. THE PATIENT WAS TRANSFERRED TO ANOTHER FACILITY WHERE HE UNDERWENT ON A RE- EVACUATION OF SUBDURAL HEMATOMA ON (B)(6) 2022 AND PRESSURE SETTING WAS INCREASED TO 110MM. HE UNDERWENT A REPEAT CT IMAGING THAT SHOWED NO SIGNIFICANT INCREMENT IN VENTRICLE SIZE AND HENCE PRESSURE SETTING WERE AGAINST CHANGED TO 140 AND LATER TO 200. HE ALSO UNDERWENT REPEAT EVACUATION OF BILATERAL SUBDURAL HEMATOMA ON (B)(6) 2022 BECAUSE OF SHUNT OVER DRAINAGE. REPEAT IMAGING ARE SUGGESTIVE THAT THE PRESSURE CHANGES IN THE SHUNT ARE NOT WORKING AND HENCE SHUNT WAS LIGATED ON (B)(6) 2022 THE VALVE WAS REMOVED.
Patient problems: Hematoma
MAUDE report 15148288 ↗InjuryAug 2, 2022Insufficient Device Problem Information; Insufficient Device Problem Information
2 OF 2 REPORTS LINKED TO MFG REPORT NUMBER: 3013886523-2022-00358. A PHYSICIAN REPORTED A HAKIM PROGRAMMABLE VALVE WAS IMPLANTED IN A 15 YEAR-OLD MALE PATIENT TO TREAT AQUEDUCTAL STENOSIS WITH HYDROCEPHALUS BUT LATER DEVELOPED BILATERAL SUBDURAL COLLECTIONS. THE SUBDURAL COLLECTIONS WERE EVACUATED, SHUNT WAS REVISED AND CHANGED TO A PROGRAMMABLE VP SHUNT WITH PRESSURE AT 70MMH2O ON (B)(6) 2022. THEN PATIENT DEVELOPED RECURRENCE OF BILATERAL SUBDURAL COLLECTION. THE PATIENT WAS TRANSFERRED TO ANOTHER FACILITY WHERE HE UNDERWENT ON A RE- EVACUATION OF SUBDURAL HEMATOMA ON (B)(6) 2022 AND PRESSURE SETTING WAS INCREASED TO 110MM. HE UNDERWENT A REPEAT CT IMAGING THAT SHOWED NO SIGNIFICANT INCREMENT IN VENTRICLE SIZE AND HENCE PRESSURE SETTING WERE AGAINST CHANGED TO 140 AND LATER TO 200. HE ALSO UNDERWENT REPEAT EVACUATION OF BILATERAL SUBDURAL HEMATOMA ON (B)(6) 2022 BECAUSE OF SHUNT OVER DRAINAGE. REPEAT IMAGING ARE SUGGESTIVE THAT THE PRESSURE CHANGES IN THE SHUNT ARE NOT WORKING AND HENCE SHUNT WAS LIGATED ON (B)(6) 2022 AND ON (B)(6) 2022 THE VALVE WAS REMOVED.
Patient problems: Hematoma
MAUDE report 15148287 ↗InjuryJul 6, 2022Infusion or Flow Problem; Infusion or Flow Problem
A PHYSICIAN REPORTED A HAKIM VALVE (823164) WAS IMPLANTED IN A PEDIATRIC MALE PATIENT VIA V-P SHUNT ON (B)(6) 2022 WITH 200MMH2O. ON JUNE 14, 2022 THE PATIENT WAS VOMITING AND UNDERDRAINAGE WAS SUSPECTED. THE VALVE WAS REMOVED AND REPLACED ON (B)(6) 2022.
Patient problems: Vomiting
MAUDE report 14934678 ↗InjuryJun 14, 2022Obstruction of Flow; Obstruction of Flow
A PHYSICIAN REPORTED A HAKIM PROGRAMMABLE VALVE (823164) WAS IMPLANTED VIA V-P SHUNT WITH UNKNOWN SETTING. OBSTRUCTION WAS SUSPECTED THUS THE VALVE WAS REMOVED AND REPLACED ON (B)(6) 2022. THE PATIENT IS NOW FOLLOWING UP.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 14687912 ↗
Other Shunt, central nervous system and components devices
- NATUS EDS3 DRAINAGE SYSTEM NT821731CNatus Medical Incorporated · Shunt, Central Nervous System And Components1 recall208 reports
- Exacta™ 46700Medtronic Ps Medical, Inc. · Shunt, central nervous system and components1 recall2 deaths163 reports
- Strata® 42866Medtronic Ps Medical, Inc. · Shunt, central nervous system and components1 death160 reports
- proGAV 2.0® FX410TChristoph Miethke GmbH & Co. KG · Shunt, central nervous system and components119 reports
- Becker® 46128Medtronic Ps Medical, Inc. · Shunt, central nervous system and components1 recall50 reports
- PROGAV 2.0 FX643TAesculap AG · Shunt, central nervous system and components100 reports
- proSA® FV701TChristoph Miethke GmbH & Co. KG · Shunt, central nervous system and components82 reports
- M.BLUE PLUS FX804TAesculap AG · Shunt, central nervous system and components82 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page